Unveiling the PROTAC Revolution: Advancing Drug Discovery through Targeted Protein Degradation
Автор: Viva Biotech
Загружено: 2024-06-28
Просмотров: 528
On June 21st, Viva Biotech hosted a Viva BioInsights webinar titled “Unveiling the PROTAC Revolution: Advancing Drug Discovery through Targeted Protein Degradation”. Dr. Michael Roy, Team Leader/Senior Research Officer, ACRF Chemical Biology Division (WEHI), along with Dr. David Taddei, Vice President of Medicinal Chemistry at Viva Biotech's subsidiary SYNthesis Med Chem, and Dr. Jean-Marc Garnier, Senior Director of Medicinal Chemistry at SYNthesis Med Chem, shared their extensive experience in the PROTAC field. They discussed the design and development processes of PROTACs, providing valuable insights from their years of research.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: